Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic DifferentiationMaría E. Figueroa, Ari Melnick, Chao Lü et al.|Cancer Cell|2010Cited by 2.7k
PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancerNorman Fultang, Neha Bhagwat|Frontiers in Oncology|2024Cited by 5